LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial.

    Barbosa-Cortes, Lourdes / Atilano-Miguel, Salvador / Martin-Trejo, Jorge Alfonso / Jiménez-Aguayo, Emmanuel / Martínez-Becerril, Fabian Ismael / López-Alarcón, Mardia / Mejía Aranguré, Juan Manuel / Maldonado-Hernández, Jorge / Delgadillo-Portillo, Suyly / Guzmán-Castro, Brenda / Delgadillo-Portillo, Jazmín / Añoveros-Barrera, Ana / Solis-Labastida, Karina Anastacia / Bautista-Martinez, Benito Alejandro / Juárez-Moya, Azalia / Hernández-Piñón, Zaira / Espinoza Hernández, Laura Eugenia / Núñez-Villegas, Nora N / Jiménez-Hernández, Elva /
    Pérez-Casillas, Ruy X

    Frontiers in endocrinology

    2023  Volume 14, Page(s) 1120364

    Abstract: Introduction: Increased triglycerides (TGs) are a major risk factor for cardiovascular disease. Furthermore, hypertriglyceridemia is commonly associated with a reduction of high-density lipoprotein cholesterol (HDL-C) and an increase in atherogenic ... ...

    Abstract Introduction: Increased triglycerides (TGs) are a major risk factor for cardiovascular disease. Furthermore, hypertriglyceridemia is commonly associated with a reduction of high-density lipoprotein cholesterol (HDL-C) and an increase in atherogenic small-dense low-density lipoprotein (LDL-C) levels. Studies provide support that polyunsaturated omega-3 fatty acids (ω3-LCPUFAs) are cardioprotective and have antithrombotic and anti-inflammatory effects. The potential effects of ω3-LCPUFAs on cardiometabolic factors and anti-inflammatory actions in children with acute lymphoblastic leukemia (ALL) are limited. This is a secondary analysis of a previous clinical trial registered at clinical trials.gov (# NCT01051154) that was conducted to analyze the effect of ω3-LCPUFAs in pediatric patients with ALL who were receiving treatment.Objective: To examine the effect of supplementation with ω3-LCPUFAs on cardiometabolic factors in children with ALL undergoing treatment.
    Methods: Thirty-four children (placebo group: 20 patients; ω3-LCPUFAs group: 14 patients) aged 6.7 ± 2.7 years who were newly diagnosed with ALL were evaluated. Children were randomized to receive either ω3-LCPUFAs or placebo capsules (sunflower oil). ω3-LCPUFAs were administered in the form of 500-mg soft capsules. The ω3-LCPUFA capsules contained 225 mg of DHA, 45 mg of EPA, and 20 mg of another ω3-LCPUFAs. The omega-3 dose was administered at a rate of 0.100 g/kg of body weight/day for three months. Main outcomes: Fasting cholesterol, HDL-C, very-low-density lipoprotein (VLDL-C), TGs, atherogenic index of plasma (AIP), android/gynoid ratio (A/GR), IL-6, TNF-α, and percentage of fat mass (DXA) were measured in all patients. Fatty acid analyses in red blood cells were performed with gas chromatography.
    Results: We found significantly lower levels of TGs (p=0.043), VLDL-C (p=0.039), IL-6 (p=0.025), and AIP (p=0.042) in the ω3-LCPUFAs group than in the placebo group at three months. In contrast, the total cholesterol concentration was higher at 3 months in the ω3-LCPUFAs group than in the placebo group (155 mg/dl vs. 129 mg/dl, p=0.009). The number of children with hypertriglyceridemia (85% vs. 50%; p=0.054) tended to be lower between the time of diagnosis and after 3 months of supplementation with ω3-LCPUFAs.
    Conclusion: These findings support the use of ω3-LCPUFAs to reduce some adverse cardiometabolic and inflammatory risk factors in children with ALL.
    Clinical trial registration: ClinicalTrials.gov, identifier NCT01051154.
    MeSH term(s) Humans ; Male ; Female ; Child ; Child, Preschool ; Fatty Acids, Omega-3/administration & dosage ; Fatty Acids, Omega-3/therapeutic use ; Hypertriglyceridemia/drug therapy ; Hypertriglyceridemia/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Treatment Outcome
    Chemical Substances Fatty Acids, Omega-3
    Language English
    Publishing date 2023-04-14
    Publishing country Switzerland
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2023.1120364
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.

    Mata-Rocha, Minerva / Rangel-López, Angelica / Jiménez-Hernández, Elva / Morales-Castillo, Blanca Angélica / González-Torres, Carolina / Gaytan-Cervantes, Javier / Álvarez-Olmos, Enrique / Núñez-Enríquez, Juan Carlos / Fajardo-Gutiérrez, Arturo / Martín-Trejo, Jorge Alfonso / Solís-Labastida, Karina Anastacia / Medina-Sansón, Aurora / Flores-Lujano, Janet / Sepúlveda-Robles, Omar Alejandro / Peñaloza-González, José Gabriel / Espinoza-Hernández, Laura Eugenia / Núñez-Villegas, Nora Nancy / Espinosa-Elizondo, Rosa Martha / Cortés-Herrera, Beatriz /
    Torres-Nava, José Refugio / Flores-Villegas, Luz Victoria / Merino-Pasaye, Laura Elizabeth / Bekker-Méndez, Vilma Carolina / Velázquez-Aviña, Martha Margarita / Pérez-Saldívar, María Luisa / Bautista-Martínez, Benito Alejandro / Amador-Sánchez, Raquel / González-Avila, Ana Itamar / Jiménez-Morales, Silvia / Duarte-Rodríguez, David Aldebarán / Santillán-Juárez, Jessica Denisse / García-Velázquez, Alejandra Jimena / Rosas-Vargas, Haydeé / Mejía-Aranguré, Juan Manuel

    International journal of molecular sciences

    2019  Volume 20, Issue 10

    Abstract: Acute lymphoblastic leukemia is the most common type of childhood cancer worldwide. Mexico City has one of the highest incidences and mortality rates of this cancer. It has previously been recognized that chromosomal translocations are important in ... ...

    Abstract Acute lymphoblastic leukemia is the most common type of childhood cancer worldwide. Mexico City has one of the highest incidences and mortality rates of this cancer. It has previously been recognized that chromosomal translocations are important in cancer etiology. Specific fusion genes have been considered as important treatment targets in childhood acute lymphoblastic leukemia (ALL). The present research aimed at the identification and characterization of novel fusion genes with potential clinical implications in Mexican children with acute lymphoblastic leukemia. The RNA-sequencing approach was used. Four fusion genes not previously reported were identified:
    MeSH term(s) Adolescent ; Adult ; CREB-Binding Protein/genetics ; Child ; Child, Preschool ; Dyneins/genetics ; Female ; GTPase-Activating Proteins/genetics ; Gene Expression Regulation, Neoplastic ; Gene Rearrangement ; Humans ; Ikaros Transcription Factor/genetics ; Infant ; Male ; Mexico ; Nuclear Proteins/genetics ; Oncogene Proteins, Fusion/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Prognosis ; Proto-Oncogene Proteins c-ets/genetics ; RNA Cap-Binding Proteins/genetics ; RNA-Binding Proteins/genetics ; Receptors, Cytoplasmic and Nuclear/genetics ; Repressor Proteins/genetics ; Translocation, Genetic/genetics ; Young Adult ; ETS Translocation Variant 6 Protein
    Chemical Substances GTPase-Activating Proteins ; IKZF1 protein, human ; NUFIP1 protein, human ; Nuclear Proteins ; Oncogene Proteins, Fusion ; Proto-Oncogene Proteins c-ets ; RNA Cap-Binding Proteins ; RNA-Binding Proteins ; Receptors, Cytoplasmic and Nuclear ; Repressor Proteins ; SNUPN protein, human ; SRGAP3 protein, human ; Ikaros Transcription Factor (148971-36-2) ; CREB-Binding Protein (EC 2.3.1.48) ; CREBBP protein, human (EC 2.3.1.48) ; DNAH14 protein, human (EC 3.6.4.2) ; Dyneins (EC 3.6.4.2)
    Language English
    Publishing date 2019-05-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms20102394
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top